Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of a New Diagnostic Test on the Care of Prostate Cancer Patients: The ProMark™ Clinical Utility Study

NCT04550416 is registered in ClinicalTrials.gov with Qure Healthcare, LLC as lead sponsor.

NCT NCT04550416
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04550416 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of a New Diagnostic Test on the Care of Prostate Cancer Patients: The ProMark™ Clinical Utility Study
Lead sponsor
Qure Healthcare, LLC
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2014
Completion date
January 31, 2015
Enrollment
217 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer